Chemoprevention of hepatocellular carcinoma

被引：0
作者：
GanneCarrie, N
Christidis, C
Beaugrand, M
机构：
来源：
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 1997年 / 21卷 / 6-7期
关键词：
hepatocellular carcinoma; cirrhosis; chemoprevention;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：447 / 449
页数：3
相关论文
共 50 条
  • [21] Targeting MEK is Effective Chemoprevention of Hepatocellular Carcinoma in TGF-α-Transgenic Mice
    Sabrina C. Wentz
    Huangbing Wu
    Michele T. Yip-Schneider
    Matthew Hennig
    Patrick J. Klein
    Judith Sebolt-Leopold
    C. Max Schmidt
    Journal of Gastrointestinal Surgery, 2008, 12 : 30 - 37
  • [22] Targeting MEK is effective chemoprevention of hepatocellular carcinoma in TGF-α-transgenic mice
    Wentz, Sabrina C.
    Wu, Huangbing
    Yip-Schneider, Michele T.
    Hennig, Matthew
    Klein, Patrick J.
    Sebolt-Leopold, Judith
    Schmidt, C. Max
    JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (01) : 30 - 37
  • [23] Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis
    Masahito Shimizu
    Takuji Tanaka
    Hisataka Moriwaki
    Seminars in Immunopathology, 2013, 35 : 191 - 202
  • [24] Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis
    Shimizu, Masahito
    Tanaka, Takuji
    Moriwaki, Hisataka
    SEMINARS IN IMMUNOPATHOLOGY, 2013, 35 (02) : 191 - 202
  • [25] Dietary Phytochemicals in the Chemoprevention and Treatment of Hepatocellular Carcinoma: In Vivo Evidence, Molecular Targets, and Clinical Relevance
    Bishayee, Anupam
    Thoppil, Roslin J.
    Waghray, Abhijeet
    Kruse, Jaclyn A.
    Novotny, Nicholas A.
    Darvesh, Altaf S.
    CURRENT CANCER DRUG TARGETS, 2012, 12 (09) : 1191 - 1232
  • [26] Hepatocellular carcinoma: Is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
    Koga, H
    CANCER, 2003, 98 (04) : 661 - 667
  • [27] Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
    Juhling, Frank
    Hamdane, Nourdine
    Crouchet, Emilie
    Li, Shen
    El Saghire, Houssein
    Mukherji, Atish
    Fujiwara, Naoto
    Oudot, Marine A.
    Thumann, Christine
    Saviano, Antonio
    Suarez, Armando Andres Roca
    Goto, Kaku
    Masia, Ricard
    Sojoodi, Mozhdeh
    Arora, Gunisha
    Aikata, Hiroshi
    Ono, Atsushi
    Tabrizian, Parissa
    Schwartz, Myron
    Polyak, Stephen J.
    Davidson, Irwin
    Schmidl, Christian
    Bock, Christoph
    Schuster, Catherine
    Chayama, Kazuaki
    Pessaux, Patrick
    Tanabe, Kenneth K.
    Hoshida, Yujin
    Zeisel, Mirjam B.
    Duong, Francois H. T.
    Fuchs, Bryan C.
    Baumert, Thomas F.
    GUT, 2021, 70 (01) : 157 - 169
  • [28] Individualized hepatocellular carcinoma risk: The challenges for designing successful chemoprevention strategies
    Della Corte, Cristina
    Aghemo, Alessio
    Colombo, Massimo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (09) : 1359 - 1371
  • [29] Individualized hepatocellular carcinoma risk: The challenges for designing successful chemoprevention strategies
    Cristina Della Corte
    Alessio Aghemo
    Massimo Colombo
    World Journal of Gastroenterology, 2013, (09) : 1359 - 1371
  • [30] Polyol profile as an early diagnostic and prognostic marker in natural product chemoprevention of hepatocellular carcinoma in diabetic rats
    Abdel-Hamid, N. M.
    Nazmy, M. H.
    Abdel-Bakey, A. I.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 92 (02) : 228 - 237
12345